DR. ALLAN S. DETSKY, MD, PhD, FRCPC, CM is Professor, Institute of Health Policy, Management and Evaluation, and Department of Medicine at the University of Toronto; former Physician-in-Chief, Mount Sinai Hospital (1997-2009); and former Head of the Division of General Internal Medicine at The Toronto Hospital and University of Toronto (1987-1997). Dr. Detsky received his B.S. from Massachusetts Institute of Technology, his M.D. from Harvard Medical School, and his Ph.D. (in Economics) from Massachusetts Institute of Technology in 1978. His research has focused on clinical epidemiology, health economics and policy, decision analysis, clinical nutrition and perioperative medicine. He has published over 300 papers, commentaries, and editorials in leading medical journals. He has attended on inpatient general internal medicine teaching services for more than 200 months in his career, an average of 5 months a year. He has served on the editorial board of the New England Journal of Medicine, and as a member of the Drug Quality and Therapeutics Committee for the Province of Ontario where he spearheaded the effort to formally include cost-effectiveness considerations into the Canadian drug reimbursement process. From 2007 to 2017 he was a Contributing Writer for the Journal of the American Medical Association. Dr. Detsky has received 2 Tony nominations as a producer (Jesus Christ Superstar 2012, Come From Away 2017 and an Olivier Award for Best Musical in 2018). In June 2018, he was appointed by the Governor General to the Order of Canada.
Clinicians’ Decisions to Use and Misuse Long-Acting Nitrates in the Management of Acute Coronary Syndromes
Published: 2006
Preferences for Short Term versus Long Term Androgen Deprivation in Prostate Cancer Survivors
Published: 2005
Evaluation of an Internet-Based Communication Tool for the Management of Patients with Heart Failure A Pilot Study
Published: 2004
Reliability Assessment of Measures Used in HIV Lipodystrophy
Published: 2004
Strategies for Pilot Trials Assessing Potentially Equivalent Therapies The Example of a Phase II Trial of Low Dose Platelet Transfusions
Published: 2003